Lessons Learned from COVID-19 Pandemic in Italy

Minni, Antonio; Ralli, Massimo; Candelori, Francesca; Cialente, Fabrizio; Ercoli, Lucia; Parlapiano, C; Greco, Antonio; Vincentiis, Marco de

doi:10.17305/bjbms.2020.4847

Cited by 13 publications

(10 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Bosnia and Herzegovina, preparedness and molecular screening of suspected subjects for imported COVID-19 resulted in the early detection and epidemiological surveillance of COVID-19 patients. We completely agree with the lesson learned by Italian colleagues that the early molecular detection of COVID-19 results in better monitoring of patients in at-home isolation [ 21 ]. Similarly, we also learned that nasopharyngeal and oropharyngeal swab testing should be performed at home by mobile and specialized microbiology teams with adequate personal protective equipment.…”

Section: Discussionsupporting

confidence: 90%

The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience

Arapović

Skočibušić

2020

Bosn J of Basic Med Sci

View full text Add to dashboard Cite

The novel coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is still progressing and has been recorded in more than 210 countries and territories worldwide. In Bosnia and Herzegovina, the first cases of COVID-19 were detected on 5th of March 2020 in the entity of Republic of Srpska and 9th of March 2020 in the entity of Federation of Bosnia and Herzegovina. Up until the 16th of May 2020, more than 2,200 COVID-19 cases were recorded in both entities, with a mortality rate of 5.8% (131 out of 2231 cases). The aim of this ongoing study is to present the current epidemiological and sociodemographic parameters of 380 COVID-19 patients diagnosed at the University Clinical Hospital Mostar (UCH Mostar) during the first two months of the COVID-19 pandemic. Out of 380 patients, 60 (15.8%) of them required hospitalization. The mortality rate was 5% (19/380). The highest mortality rate of 15.2% (12/79) was recorded in the patients age ≥65 years. In addition to this single-centre experience of the ongoing COVID-19 pandemic, we discuss the epidemiological measures imposed in Bosnia and Herzegovina, with emphasis on the restrictive ones. The COVID-19 pandemic is still ongoing in Bosnia and Herzegovina.

show abstract

Section: Discussionsupporting

confidence: 90%

The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience

Arapović

Skočibušić

2020

Bosn J of Basic Med Sci

View full text Add to dashboard Cite

show abstract

“…Patients with COVID-19 were instructed to consult emergency services only in case of respiratory difficulties [34]. In his commentary, Minni et al recalled the importance of early detection for the rapid and effective management of patients [35].…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Strategies to Fight COVID-19: The French Paradigm

Giraud-Gatineau

Colson

Chaudet

et al. 2021

JCM

View full text Add to dashboard Cite

(1) Background: We collected COVID-19 mortality data and the age distribution of the deceased in France and other European countries, as well as specifically in the cities of Paris and Marseille, and compared them. (2) Methods: Data on mortality related to COVID-19 and the associated age distribution were collected from government institutions in various European countries. In France, data were obtained from INSEE and Santé Publique France. All-cause mortality was also examined in order to study potential excess mortality using EuroMOMO. The Marseille data came from the epidemiological surveillance system. (3) Results: France is one of the European countries most impacted by COVID-19. Its proportion of deaths in people under 60 years of age is higher (6.5%) than that of Italy (4.6%) or Spain (4.7%). Excess mortality (5% more deaths) was also observed. Ile-de-France and the Grand-Est are the two French regions with the highest mortality. The proportion of deaths in the under-60 age group was considerable in Ile-de-France (9.9% vs. 4.5% in the Southern region). There are significantly higher numbers of patients hospitalized, in intensive care and deceased in Paris than in Marseille. (4) Conclusions: No patient management, i.e., from screening to diagnosis, including biological assessment and clinical examination, likely explains the high mortality associated with COVID-19.

show abstract

“…Very recently, people felt a sort of harassment merged with fear, due to the paroxysmal exposition of images and videos showing pandemic effects, with deaths, sick people and hospitals and probably even caregivers performing swabbing to any motorist on the road, the so-called “drive-thru-swab” or DTS, aroused some concern. Physicians exist suggesting a house-to-house swabbing, in order to thoroughly mapping the highest number of resident people for COVID-19 positivity [ 5 , 6 ]. DTS appears as a rapid and straightforward approach to collect the highest amount of swabs, but is usually performed in a not standardized environment (open air instead of a lab), often with hasty operators to prevent traffic and in a context particularly enriched in airborne pollutants, such as engine emission exhausts [ 7 , 8 ].…”

Section: Current Statusmentioning

confidence: 99%

Swabbing Thoroughly People for COVID-19 Positivity. Insights on the Main Bio-analytical and Microbiology Bias and Concerns

Chirumbolo

2020

Curr Microbiol

View full text Add to dashboard Cite

Thorough swabbing is becoming an increasing approach to fight COVID-19 transmission, particularly among asymptomatic subjects, who are thought to represent the majority of potentially-contacting people. Particularly in the current management of COVID-19 emergency, the 3T approach, i.e., testing, tracing and treating, is felt as particularly crucial to fight COVID-19 pandemic. Aside from the time-consuming, cost expensive and the many burdensome issues associated with a thorough swabbing, adopting easy-to-make criteria such as "drive-thru-swab" may exacerbate the burden of critical biases and pre-analytical errors, which may impair the analytical reliability of these tests. This manuscript addresses some major points about.

show abstract

Lessons Learned from COVID-19 Pandemic in Italy

Cited by 13 publications

References 15 publications

The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience

The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience

Evaluation of Strategies to Fight COVID-19: The French Paradigm

Swabbing Thoroughly People for COVID-19 Positivity. Insights on the Main Bio-analytical and Microbiology Bias and Concerns

Contact Info

Product

Resources

About